Crossref
Aflibercept versus Brolucizumab in Resistant Diabetic Macular Edema
The Egyptian Journal of Hospital Medicine · 01.01.2026 · 102 (1) · 1296-1304
DOI: 10.21608/ejhm.2026.491923 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Egyptian Journal of Hospital Medicine, online erschienen am 01.01.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Aflibercept versus Brolucizumab in Resistant Diabetic Macular Edema. The Egyptian Journal of Hospital Medicine, 102(1), 1296-1304. https://doi.org/10.21608/ejhm.2026.491923
Vancouver
Aflibercept versus Brolucizumab in Resistant Diabetic Macular Edema. The Egyptian Journal of Hospital Medicine. 2026;102(1):1296-1304. doi:10.21608/ejhm.2026.491923
BibTeX
@article{euvimed2026,
title = {Aflibercept versus Brolucizumab in Resistant Diabetic Macular Edema},
journal = {The Egyptian Journal of Hospital Medicine},
year = {2026},
volume = {102},
number = {1},
pages = {1296--1304},
doi = {10.21608/ejhm.2026.491923}
}
EUVIMED